DENTSPLY SIRONA (XRAY): SEC ends probe, no enforcement action

DENTSPLY SIRONA announced that the SEC’s Division of Enforcement has concluded its investigation and does not intend to recommend any enforcement action against the company.

Rhea-AI Filing Summary

DENTSPLY SIRONA announced that the SEC’s Division of Enforcement has concluded its investigation and does not intend to recommend any enforcement action against the company. The inquiry, initiated by the SEC in connection with an internal review led by the Audit and Finance Committee into certain financial reporting matters raised by employees, began in May 2022 and closed on October 14, 2025. The company had voluntarily contacted the SEC and fully cooperated throughout.

The closure removes a regulatory overhang tied to past financial reporting questions and reflects the regulator’s decision not to pursue action. Management characterized the outcome as a significant and favorable development.

Insights

Regulatory & Governance Analyst

SEC probe closed with no enforcement; regulatory overhang lifted.

DENTSPLY SIRONA reported that the SEC ended its investigation and does not intend to recommend enforcement action. The matter stemmed from an audit committee-led review of financial reporting issues raised by employees, with the company voluntarily engaging and cooperating with the regulator.

Practically, this removes a potential legal and compliance risk that can weigh on valuation and stakeholder confidence. No penalties or remedial orders were disclosed in the announcement.

The key milestone is the closure date on October 14, 2025. Subsequent filings may provide any related governance or control updates mentioned by management in the normal course.

8-K Event Classification

Item 8.01 — Other Events

1 item

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did DENTSPLY SIRONA (XRAY) announce regarding the SEC investigation?

The SEC’s Division of Enforcement concluded its investigation and does not intend to recommend any enforcement action against the company.

When did the SEC investigation into DENTSPLY SIRONA (XRAY) conclude?

The investigation concluded on October 14, 2025, with no enforcement action recommended.

What triggered the SEC’s review of DENTSPLY SIRONA (XRAY)?

It related to an audit committee-led internal investigation into certain financial reporting matters raised by current and former employees.

Did DENTSPLY SIRONA (XRAY) cooperate with the SEC?

Yes. The company voluntarily contacted the SEC and fully cooperated throughout the investigation.

How did DENTSPLY SIRONA (XRAY) characterize the outcome?

Management described the closure without enforcement action as a significant and favorable development.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/14/2025 - 04:26 PM Learn about SEC filing dates

0000818479false00008184792025-10-142025-10-14

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

October 14, 2025

Date of Report (Date of earliest event reported)

DENTSPLY SIRONA Inc.

(Exact name of registrant as specified in its charter)

Delaware

0-16211

39-1434669

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

13320 Ballantyne Corporate Place,

Charlotte

North Carolina

28277-3607

(Address of principal executive offices)

(Zip Code)

(844) 848-0137

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, par value $0.01 per share			XRAY			The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

o

Item 8.01 Other Events

On October 14, 2025, DENTSPLY SIRONA Inc. (the “Company”) announced that the Division of Enforcement of the Securities and Exchange Commission (the “SEC”) has concluded its investigation of the Company commenced in May 2022 (the “SEC Investigation”) and does not intend to recommend any enforcement action against the Company. The SEC Investigation related to the Company’s investigation led by the Audit and Finance Committee, initiated in March 2022, into allegations regarding certain financial reporting matters submitted by current and former employees of the Company. As previously disclosed, the Company voluntarily contacted the SEC regarding these matters and has fully cooperated with the SEC throughout the course of the SEC Investigation. The Company views the closure without any enforcement action as a significant and favorable development.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                         DENTSPLY SIRONA Inc.

By:						/s/ Daniel T. Scavilla
						Daniel T. Scavilla
						President and Chief Executive Officer

Date: October 14, 2025